Literature DB >> 2488177

Beta-2 microglobulin removal during continuous ambulatory peritoneal dialysis (CAPD).

M J Lysaght1, C A Pollock, J E Moran, L S Ibels, P C Farrell.   

Abstract

Beta-2 microglobulin (B2M) handling in continuous ambulatory peritoneal dialysis (CAPD) was characterized in acute and chronic clinical studies. Average clearance rate was 0.7 mL/min and mean mass transfer coefficient, KoA, was calculated to be 0.95 cm2/min; these values are in the range expected from extrapolation of published data for other large solutes. In chronic studies with both anuric and oliguric populations, CAPD was shown to be much more effective than conventional hemodialysis in removing B2M and, in fact, CAPD removal rates were equivalent to those reported for high flux dialysis therapies. However, this greater extraction was not associated with any clinically significant reduction in circulating plasma concentrations. These trends remained valid in both the anuric and oliguric subsets of the study population.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2488177

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  2 in total

1.  Serum β2-microglobulin as a predictor of residual kidney function in peritoneal dialysis patients.

Authors:  David A Jaques; Andrew Davenport
Journal:  J Nephrol       Date:  2020-12-03       Impact factor: 3.902

2.  Development and Validation of Residual Kidney Function Estimating Equations in Dialysis Patients.

Authors:  Dominik Steubl; Li Fan; Wieneke M Michels; Lesley A Inker; Hocine Tighiouart; Friedo W Dekker; Raymond T Krediet; Andrew L Simon; Meredith C Foster; Amy B Karger; John H Eckfeldt; Hongyan Li; Jiamin Tang; Yongcheng He; Minyan Xie; Fei Xiong; Hongbo Li; Hao Zhang; Jing Hu; Yunhua Liao; Xudong Ye; Tariq Shafi; Wei Chen; Xueqing Yu; Andrew S Levey
Journal:  Kidney Med       Date:  2019-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.